DTaP vaccine paediatric - Baxter International

Drug Profile

DTaP vaccine paediatric - Baxter International

Alternative Names: Certiva; Certiva-EU

Latest Information Update: 16 Mar 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator North American Vaccine
  • Developer Baxter International
  • Class Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Market Withdrawal Diphtheria; Pertussis; Tetanus

Most Recent Events

  • 27 Jun 2000 North American Vaccine has been acquired by and merged into Baxter International
  • 30 Oct 1999 Withdrawn for Diphtheria in USA (IM)
  • 30 Oct 1999 Withdrawn for Pertussis in USA (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top